Opposing Brain Differences in 16p11.2 Deletion and Duplication Carriers

被引:122
|
作者
Qureshi, Abid Y. [1 ,2 ,3 ]
Mueller, Sophia [5 ,6 ]
Snyder, Abraham Z. [7 ,8 ]
Mukherjee, Pratik [9 ]
Berman, Jeffrey I. [11 ]
Roberts, Timothy P. L. [11 ]
Nagarajan, Srikantan S. [9 ]
Spiro, John E. [12 ]
Chung, Wendy K. [13 ]
Sherr, Elliott H. [10 ]
Buckner, Randy L. [1 ,2 ,4 ,5 ]
机构
[1] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA
[2] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA
[3] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA
[6] Univ Munich, Inst Clin Radiol, D-81377 Munich, Germany
[7] Washington Univ, Sch Med St Louis, Dept Neurol, St Louis, MO 63110 USA
[8] Washington Univ, Sch Med St Louis, Dept Radiol, St Louis, MO 63110 USA
[9] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA
[10] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA
[11] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA
[12] Simons Fdn, New York, NY 10010 USA
[13] Columbia Univ, Med Ctr, Dept Pediat & Med, New York, NY 10032 USA
来源
JOURNAL OF NEUROSCIENCE | 2014年 / 34卷 / 34期
关键词
16p11.2; ASD; CNV; copy number variation; morphometry; structural MRI; SURFACE-BASED ANALYSIS; WHITE-MATTER; HEAD CIRCUMFERENCE; COSTELLO SYNDROME; AUTISM; CHILDREN; VOLUME; PHENOTYPES; AMYGDALA; ADULTS;
D O I
10.1523/JNEUROSCI.1366-14.2014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Deletions and duplications of the recurrent similar to 600 kb chromosomal BP4-BP5 region of 16p11.2 are associated with a broad variety of neurodevelopmental outcomes including autism spectrum disorder. A clue to the pathogenesis of the copy number variant (CNV)'s effect on the brain is that the deletion is associated with a head size increase, whereas the duplication is associated with a decrease. Here we analyzed brain structure in a clinically ascertained group of human deletion (N = 25) and duplication (N = 17) carriers from the Simons Variation in Individuals Project compared with age-matched controls (N = 29 and 33, respectively). Multiple brain measures showed increased size in deletion carriers and reduced size in duplication carriers. The effects spanned global measures of intracranial volume, brain size, compartmental measures of gray matter and white matter, subcortical structures, and the cerebellum. Quantitatively, the largest effect was on the thalamus, but the collective results suggest a pervasive rather than a selective effect on the brain. Detailed analysis of cortical gray matter revealed that cortical surface area displays a strong dose-dependent effect of CNV (deletion > control > duplication), whereas average cortical thickness is less affected. These results suggest that the CNV may exert its opposing influences through mechanisms that influence early stages of embryonic brain development.
引用
收藏
页码:11199 / 11211
页数:13
相关论文
共 50 条
  • [41] Autonomic failure associated with 16p11.2 duplication in two siblings
    Denkensohn, Cole P.
    Cook, Glen A.
    CLINICAL AUTONOMIC RESEARCH, 2024, 34 (06) : 603 - 605
  • [42] Hyperinsulinaemic Hypoglycaemia: A New Presentation of 16p11.2 Duplication Syndrome
    Conwell, Louise
    Flanagan, Sarah
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 159 - 159
  • [43] Insight into inter-individual phenotypic differences in Korean patients with 16p11.2 deletion
    Han, Ji Yoon
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1440 - 1440
  • [44] ALTERED BRAIN CONNECTIVITY IN PATIENTS WITH 16P11.2
    Moreau, Clara
    Urchs, Sebastian
    Evans, Alan
    Lewis, John D.
    Bellec, Pierre
    Jacquemont, Sebastien
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S895 - S896
  • [45] Understanding copy number variations through their genes: a molecular view on 16p11.2 deletion and duplication syndromes
    Leone, Roberta
    Zuglian, Cecilia
    Brambilla, Riccardo
    Morella, Ilaria
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [46] Overexpression of CD47 is associated with brain overgrowth and 16p11.2 deletion syndrome
    Li, Jingling
    Brickler, Thomas
    Banuelos, Allison
    Marjon, Kristopher
    Shcherbina, Anna
    Banerjee, Sravani
    Bian, Jing
    Narayanan, Cyndhavi
    Weissman, Irving L.
    Chetty, Sundari
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (15)
  • [47] Hyperinsulinaemic hypoglycaemia: A new presentation of 16p11.2 deletion syndrome
    Kostopoulou, Eirini
    Dastamani, Antonia
    Caiulo, Silvana
    Antell, Hannah
    Flanagan, Sarah E.
    Shah, Pratik
    CLINICAL ENDOCRINOLOGY, 2019, 90 (05) : 766 - 769
  • [48] 16p11.2 Deletion Syndrome in Prenatal Diagnosis - a rare case
    Freitas, Manuela Mota
    Candeias, Cristina
    Pires, Silvia
    Oliva-Teles, Natalia
    Tavares, Purificacao
    Rodrigues, Maria Do Ceu
    Fonseca E Silva, Maria Da Luz
    MOLECULAR CYTOGENETICS, 2017, 10
  • [49] Language and Communication Deficits in Chromosome 16p11.2 Deletion Syndrome
    Salud Jimenez-Romero, Ma
    Fernandez-Urquiza, Maite
    Benitez-Burraco, Antonio
    JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH, 2022, 65 (12): : 4724 - 4740
  • [50] Health supervision for children and adolescents with 16p11.2 deletion syndrome
    Chung, Wendy K.
    Herrera, Faranak F.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2023, 9 (04):